The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Benzodiazepines: Risks and benefits. A reconsideration
Open accessAbstract
Over the last decade there have been further developments in our knowledge of the risks and benefits of benzodiazepines, and of the risks and benefits of alternatives to benzodiazepines. Representatives drawn from the Psychopharmacology Special Interest Group of the Royal College of Psychiatrists and the British Association for Psychopharmacology together examined these developments, and have provided this joint statement with recommendations for clinical practice. The working group was mindful of widespread concerns about benzodiazepines and related anxiolytic and hypnotic drugs. The group believes that whenever benzodiazepines are prescribed, the potential for dependence or other harmful effects must be considered. However, the group also believes that the risks of dependence associated with long-term use should be balanced against the benefits that in many cases follow from the short or intermittent use of benzodiazepines and the risk of the underlying conditions for which treatment is being provided.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They have been shown to be effective in the acute treatment of generalized anxiety disorder, social anxiety, panic disorder, and insomnia [8].”
Citations
Cites
Wilson, S., Nutt, D., Alford, C., Argyropoulos, S., Baldwin, D., Bateson, A., Britton, T., Crowe, C., Dijk, D.-J., Espie, C., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110379307 · Cited by 634
Self-citationBaldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., et al. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105059253 · Cited by 617
Self-citationLingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332
Self-citationDell’osso, B., & Lader, M. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2011.11.003 · Cited by 210
Uncritical positive regard? Issues in the efficacy and safety of psychotherapy
Nutt, D. J., & Sharpe, M. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107086283 · Cited by 123
Self-citationSubstitution therapy for alcoholism: time for a reappraisal?
Chick, J., & Nutt, D. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111408463 · Cited by 80
Self-citationNeuropharmacology of Benzodiazepines
Stephens, D., & King, S. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398335-0.00059-5 · Cited by 2
Self-citation
Cited by
Sorted by citations
Items 101–200 of 250
González‐Chica, D. A., Begum, M., Bernardo, C., Hoon, E. A., Sweetman, A., & Stocks, N. (2022) · Drug and Alcohol Review · doi:10.1111/dar.13561 · Cited by 8
Best practices in benzodiazepine prescribing and management in primary care
Champion, C., & Kameg, B. (2021) · The Nurse Practitioner · doi:10.1097/01.npr.0000733684.24949.19 · Cited by 8
Zamboni, L., Portoghese, I., Congiu, A., Zandonai, T., Casari, R., Fusina, F., Bertoldi, A., & Lugoboni, F. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.811130 · Cited by 10
Stapel, B., Alvarenga, M. E., & Kahl, K. G. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1490585 · Cited by 8
Pétein, C., Spinewine, A., Laroche, M., Niquille, A., & Henrard, S. (2023) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2023.05.010 · Cited by 7
Stamenković, D., Selvaraj, S., Venkatraman, S., Arshad, A., Rančić, N., Dragojevic-Simic, V. M., Miljković, M. N., & Cattano, D. (2020) · Minerva Anestesiologica · doi:10.23736/s0375-9393.20.14259-7 · Cited by 8
Anxiety disorders, post-traumatic stress disorder, and obsessive–compulsive disorder
Impey, B., Gordon, R. P., & Baldwin, D. S. (2020) · Medicine · doi:10.1016/j.mpmed.2020.08.005 · Cited by 10
Self-citationGABAergic Involvement in Selective Attention
Faßbender, K., Baumert, P. M., Wintergerst, M. W. M., Terheyden, J. H., Aslan, B., Harmening, W. M., & Ettinger, U. (2023) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_01989 · Cited by 6
The role of benzodiazepines in common conditions: a narrative review focusing on lormetazepam
Pallanti, S. (2024) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000529 · Cited by 7
Hood, S. D. (2015) · Australasian Psychiatry · doi:10.1177/1039856215588209 · Cited by 6
Carlo, V. D., Grancini, B. M., Vismara, M. E. M., Benatti, B., Arici, C., Cremaschi, L., Cirnigliaro, G., Degoni, L., Oldani, L., Palazzo, C., et al. (2019) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2695 · Cited by 6
GABAergic modulation of performance in response inhibition and interference control tasks
Faßbender, K., Bey, K., Lippold, J. V., Aslan, B., Hurlemann, R., & Ettinger, U. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211032440 · Cited by 9
The effect of benzodiazepines on exercise in healthy adult participants: A systematic review
Holgado, D., Manresa‐Rocamora, A., Zamboni, L., Lugoboni, F., Peiró, A. M., & Zandonai, T. (2021) · Journal of Addictive Diseases · doi:10.1080/10550887.2021.1990640 · Cited by 6
Benzodiazepine use and associated factors in elderly in the city of Dourados, MS, Brazil
Cunha, C. D. D. A., de Souza, M. C. C., Cattanio, G. A. A., Iahnn, S. R., & Lima, R. D. C. (2015) · Jornal Brasileiro de Psiquiatria · doi:10.1590/0047-2085000000080 · Cited by 6
The clinical implications of personality‐generated mental illness
Tyrer, P. J., & Yang, M. (2015) · Personality and Mental Health · doi:10.1002/pmh.1286 · Cited by 5
Substance-Induced Anxiety and Co-occurring Anxiety Disorders
Blaney, D., Jackson, A. K., Toy, O., Fitzgerald, A., & Piechniczek‐Buczek, J. (2019) · Current clinical psychiatry · doi:10.1007/978-3-319-23961-3_8 · Cited by 6
Zandonai, T., Peiró, A. M., Fusina, F., Lugoboni, F., & Zamboni, L. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1066330 · Cited by 5
Benzodiazepines and z-drugs - between treatment effectiveness and the risk of addiction
Cabaj, J., Bargieł, J., & Soroka, E. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.46.01.032 · Cited by 5
Durand, L., Keenan, E., O’Reilly, D., Bennett, K., O’Hara, A., & Cousins, G. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05195-9 · Cited by 5
Martínez-León, M. A., Carballo, J. L., & Pérez‐Jover, V. (2023) · Actas Españolas de Psiquiatría · Cited by 5
Magnesium in the treatment of alcohol withdrawal syndrome: a multicenter randomized controlled trial
Airagnes, G., Valter, R., Ducoutumany, G., Vansteene, C., Trabut, J., Gorwood, P. A. P. M., Dubertret, C., Matta, J., Charles‐Nelson, A., & Limosin, F. (2023) · Alcohol and Alcoholism · doi:10.1093/alcalc/agad021 · Cited by 5
Partinen, M. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6578-6_30 · Cited by 6
Brandstetter, L., Grau, A., Heuschmann, P. U., Müller-Reiter, M., Salmen, J., Störk, S., Wöckel, A., & Reese, J. (2025) · BMC Cancer · doi:10.1186/s12885-025-13548-8 · Cited by 5
Krüger, C., Lindberg, M. H., Burmester, S., Franck, J., & Westman, J. (2025) · BMC Public Health · doi:10.1186/s12889-025-23920-9 · Cited by 6
Rivera, Z. A. A., Talubo, N. D. D., & Cabrera, H. S. (2024) · Life · doi:10.3390/life14091182 · Cited by 4
Addiction to Prescription Medication: Benzodiazepines, Z-Drugs and Gabapentinoids
Rourke, E. D., & Law, F. D. (2021) · Cambridge University Press eBooks · doi:10.1017/9781911623199.005 · Cited by 4
Weiss, O., Eyre, A., Alon-Ellenbogen, D., & Stein, G. Y. (2024) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5812 · Cited by 4
Carton, L., Auger, F., Laloux, C., Durieux, N., Kyheng, M., Potey, C., Bergeron, S., Rolland, B., Deguil, J., & Bordet, R. (2022) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12764 · Cited by 4
Anxiolytics: Misuse, Dependence, and Withdrawal Syndromes
Tang, V. M., & Davies, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_405 · Cited by 4
Self-citationAnxiety disorders, post-traumatic stress disorder and obsessive–compulsive disorder
Fagan, H. A., Impey, B., & Baldwin, D. S. (2024) · Medicine · doi:10.1016/j.mpmed.2024.05.014 · Cited by 5
Self-citationTherapie der Benzodiazepinabhängigkeit
Soyka, M., & München, B. (2019) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-0836-7514 · Cited by 5
Khacheva, K. K., Khakimova, G. R., Glazunov, A. B., & Fateeva, V. V. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.92207 · Cited by 4
Treating Insomnia in Older Adult Patients: Limiting Benzodiazepine Use
Pergolizzi, J. V., Taylor, R. J., LeQuang, J. A., Gould, E. M., & Raffa, R. B. (2019) · Pharmacology & Pharmacy · doi:10.4236/pp.2019.103010 · Cited by 4
Benzodiazepines Dependence: Addiction to Legally Prescribed Substances
S. Anna Gandra, S., D Almeida, A. L., & M. Teixeira, Z. (2019) · Journal of Forensic Psychology · doi:10.35248/2475-319x.19.4.149 · Cited by 4
Takagaki, K., Ohno, Y., Otsuki, T., Kubota, A., Kijima, T., & Tanaka, T. (2025) · Thoracic Cancer · doi:10.1111/1759-7714.70081 · Cited by 3
Allary, A., Proulx-Tremblay, V., Bélanger, C., Hudon, C., O’Connor, K. P., Roberge, P., Vasiliadis, H., Desrosiers, C., Cruz-Santiago, D., & Grenier, S. (2024) · Aging & Mental Health · doi:10.1080/13607863.2024.2372473 · Cited by 3
Effects of Mindfulness on Postoperative Pain, Anxiety, and Opioid Use: An Integrative Review
Miller, M. A., Ye, L., van Pelt, M., & Pavone, K. J. (2025) · Pain Management Nursing · doi:10.1016/j.pmn.2025.04.004 · Cited by 3
Kul, A., Al, S., Dinçel, D., & Sağırlı, O. (2025) · Biomedical Chromatography · doi:10.1002/bmc.70155 · Cited by 3
Impact of Pregnancy on Psychotropic Medication Prescription: a French Cohort Study
Apter, G., Devouche, É., & Becquemont, L. (2014) · Therapies · doi:10.2515/therapie/2014212 · Cited by 3
Drug and alcohol addiction: new challenges
Luty, J. S. (2014) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.114.012583 · Cited by 3
Oral premedication with benzodiazepines
Simić, D., Stanković, Z., Stevic, M. M., & Petrov, I. (2023) · Galenika Medical Journal · doi:10.5937/galmed2307041s · Cited by 3
Umarudeen, A. M., Khan, F., Tahir, Y., & Modibbo, M. R. (2023) · International Journal of Biochemistry Research & Review · doi:10.9734/ijbcrr/2023/v32i8831 · Cited by 3
Aralia continentalis Root Enhances Non-Rapid Eye Movement Sleep by Activating GABAA Receptors
Yoon, M., Lim, D. W., Jung, J., Jung, Y. S., Lee, C.-H., & Um, M. Y. (2023) · Nutrients · doi:10.3390/nu15245020 · Cited by 3
Chen, J., Chen, Z., Zhang, Y., Fan, X., Zhang, C., Zhu, J., Song, C., Zhang, S., Zhang, D., Tang, L., et al. (2024) · Addiction Biology · doi:10.1111/adb.13425 · Cited by 3
Chapoutot, M., Meloni, F., Peter‐Derex, L., Bastuji, H., Leslie, W., Schoendorff, B., Heinzer, R. C., Nicolas, A., Higgins, S., Bourgeois, A., et al. (2025) · Journal of Behavioral and Cognitive Therapy · doi:10.1016/j.jbct.2025.100533 · Cited by 4
Missbrauch und Abhängigkeit von Benzodiazepinen und Z-Drugs
Soyka, M. (2021) · Nervenheilkunde · doi:10.1055/a-1523-5718 · Cited by 3
Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users
Rowan‐Robinson, K. (2019) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000161 · Cited by 3
Treatment of anxiety disorders
Baldwin, D. S., & Huneke, N. T. M. (2020) · doi:10.1093/med/9780198713005.003.0092 · Cited by 3
Self-citationO uso abusivo de benzodiazepínicos em pacientes adultos
do Nascimento, K. S., Andrade, A. C. S., Lobato, A. C. D. S., Holanda, J. A. D. S., & Castro, J. D. S. (2022) · Research Society and Development · doi:10.33448/rsd-v11i12.34076 · Cited by 4
Benzodiazepines: Dependence and addiction in general practice
Gleeson, D. (2019) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738019869730 · Cited by 3
Benzodiazepines: Pharmacology Up-to-Date and Practical Issues
Kang, U. G., Kim, S. H., Lee, N. Y., Lee, K. Y., Kim, Y. S., & Chung, I. W. (2023) · 신경정신의학 · doi:10.4306/jknpa.2023.62.1.1 · Cited by 2
Tjiong, E. B., Buwalda, V. J. A., & Oene, G. H. D. W.-V. (2019) · Addiction Research & Theory · doi:10.1080/16066359.2019.1596260 · Cited by 2
Boström, P., Grundström, N., Sand, P. K., & Strand, J. (2020) · Ethical Human Psychology and Psychiatry · doi:10.1891/ehpp-d-20-00009 · Cited by 2
Study protocol—Evoked craving in high-dose benzodiazepine users
Zamboni, L., Toldo, S., Fusina, F., Mattiello, M., Mannari, V., Campagnari, S., Schiavone, V., Congiu, A., Verlato, G., Chiamulera, C., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.956892 · Cited by 2
Alshahrani, N. Z., Alarifi, A. M., Alotaibi, W. S., Alsayed, A. A., Alwasm, K. S. L., Alhunti, A. A., AlDahleh, L. A., Alshahrani, M. S., Albeshry, A. M., & Aljunaid, M. A. (2024) · Health Science Reports · doi:10.1002/hsr2.70170 · Cited by 2
Pharmacological management of panic disorder
Guaiana, G., & Davies, S. (2025) · BJPsych Advances · doi:10.1192/bja.2025.10117 · Cited by 3
Self-citationSoyka, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00033-5 · Cited by 2
Clinical pharmacology of anxiolytics
Bourin, M. (2018) · Archives of Depression and Anxiety · doi:10.17352/2455-5460.000029 · Cited by 2
Umarudeen, A. M., & Magaji, M. G. (2020) · International Neuropsychiatric Disease Journal · doi:10.9734/indj/2020/v14i230123 · Cited by 2
An update on the pharmacological treatment of anxiety and related disorders
Outhoff, K. (2016) · South African Family Practice · doi:10.4102/safp.v58i5.4561 · Cited by 1
Dubey, A., Kumari, M., Dwivedi, M., Ghosh, N. S., & Tripathy, D. (2023) · IP International Journal of Comprehensive and Advanced Pharmacology · doi:10.18231/j.ijcaap.2023.041 · Cited by 1
Anders, R., Chapoutot, M., Meloni, F., Peter‐Derex, L., Gustin, M., & Putois, B. (2024) · Journal of Behavioral and Cognitive Therapy · doi:10.1016/j.jbct.2024.100510 · Cited by 1
Yan, D., Wang, Y., Li, J., Wang, L., Yao, Y., & Deng, J. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1414143 · Cited by 1
Zhang, X., Wang, D., Cui, J., Fan, B., Wang, F., & Lu, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010371 · Cited by 2
Kubová, H., Tsenov, G., Conti, A., Negri, A., Roubalová, L., & Mareš, P. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1725780 · Cited by 1
Koroglu, S., & Durat, G. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.01.028 · Cited by 1
Varma, S. (2012) · Medicine · doi:10.1016/j.mpmed.2012.09.016 · Cited by 1
Do Benzodiazepines Still Need to be Used?
Bourin, M. (2017) · Open access Journal of Neurology & Neurosurgery · doi:10.19080/oajnn.2017.05.555670 · Cited by 1
Pharmacologie des anxiolytiques
Bordet, R., Carton, L., Deguil, J., & Dondaine, T. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-75299-5.00012-5 · Cited by 1
Drugs to Treat Anxiety and Insomnia
Baldwin, D. S., & Huneke, N. T. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623465.010 · Cited by 1
Self-citationMagnetic Effects in Brain Chemistry
Yerkin, A., Valentina, Y., Tussupbayev, N., Tatyana, S., Zhadyra, Y., Maxat, B., & Evgeniy, B. (2016) · Journal of Chemistry and Chemical Engineering · doi:10.17265/1934-7375/2016.02.008 · Cited by 1
Uso concomitante de ansiolíticos e plantas medicinais: Será que há risco?
Lima, G., Costa, T., Antunes, A. A., & Gonzaga, R. V. (2022) · Research Society and Development · doi:10.33448/rsd-v11i7.30219 · Cited by 1
Nishtala, P. S., & Chyou, T. (2022) · Drugs & Aging · doi:10.1007/s40266-022-00965-8 · Cited by 1
Considering Medication Exposure in Genomic Association Studies of Cognition in Psychotic Disorders
Eum, S., Hill, S. K., & Bishop, J. R. (2022) · Pharmacogenomics · doi:10.2217/pgs-2022-0070 · Cited by 1
Re-evaluating benzodiazepines for anxiety disorders – déjà-vu all over again?
Anderson, I. M. (2023) · BJPsych Advances · doi:10.1192/bja.2022.85 · Cited by 1
Baldwin, D. S., Impey, B., & Masdrakis, V. G. (2024) · Cambridge University Press eBooks · doi:10.1017/9781911623861.014 · Cited by 2
Self-citationCurrent practice in pharmacological treatment of generalized anxiety disorder
Useinova, A. N., Ayrapetova, A. A., Savshak, M. V., Li, Y. R., Tarusov, N. I., Kondakov, D. M., Boyko, M. V., Solomko, D. V., Seitmemetova, U. M., & Davydova, D. S. (2024) · Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery) · doi:10.33920/med-01-2407-10 · Cited by 1
Роль та місце бензодіазепінів у фармакотерапії посттравматичного стресового розладу
Burchinsky, S. G. (2018) · INTERNATIONAL NEUROLOGICAL JOURNAL · doi:10.22141/2224-0713.4.98.2018.139428 · Cited by 1
Anxiety disorder treatment guidelines: Little by little a consensus emerges
Hood, S. D., & Davies, S. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418815974 · Cited by 1
Self-citationBordet, R., Carton, L., Deguil, J., & Dondaine, T. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-75299-5.00013-7 · Cited by 1
Consumption of psychotropic medicines at a referral hospital Namibia: findings and implications
Kafula, M. N., Ugburo, E. O., & Kibuule, D. (2020) · African Health Sciences · doi:10.4314/ahs.v20i2.57 · Cited by 1
Assessing the clinical utility of the severity dependence scale for benzodiazepine use disorder
Lowton, K., & Chiba, G. (2021) · South African Journal of Psychiatry · doi:10.4102/sajpsychiatry.v27i0.1571 · Cited by 1
Interventions for benzodiazepine withdrawal: Perceptions of benzodiazepine counsellors
Wurf, G., & Swing, A. (2021) · Counselling and Psychotherapy Research · doi:10.1002/capr.12453 · Cited by 1
Chen, Y., Wang, F., Cui, L., Huang, H., Kong, S., Qian, N., Zhang, M., Lyu, D., Wang, M., Liu, X., et al. (2022) · Disease Markers · doi:10.1155/2022/6799898 · Cited by 2
RetractedPharmacological class interventions for benzodiazepine withdrawal discontinuation: a meta-analysisPreprint
Fluyau, D., Revadigar, N., Mitra, P., & Pierre, C. G. (2020) · medRxiv · doi:10.1101/2020.07.07.20148403 · Cited by 1
Pharmacological Treatment of Generalized Anxiety Disorder (GAD)
Baldwin, D. S. (2020) · Wiley eBooks · doi:10.1002/9781119189909.ch14 · Cited by 1
Self-citationDexmedetomidine Use in Alcohol Withdrawal Syndrome: A Retrospective Chart ReviewPreprint
Stefanilo, E. (2020) · doi:10.28971/532020se98 · Cited by 1
Depression and Anxiety Disorders
(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg003 · Cited by 1
Allgulander, C., & Nutt, D. (2014) · Springer eBooks · doi:10.1007/978-3-642-27772-6_113-2 · Cited by 1
Self-citation(2018) · Elsevier eBooks · doi:10.1016/b978-3-437-23672-3.00005-6 · Cited by 1
Therapie der Benzodiazepinabhängigkeit
Soyka, M. (2018) · PSYCH up2date · doi:10.1055/a-0525-5277 · Cited by 1
Siani-Morello, M. R. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.60.2014.tde-30102014-163819
Managing generalised anxiety disorder
Greener, M. (2014) · British Journal of Mental Health Nursing · doi:10.12968/bjmh.2014.3.3.100
Substance misuse in young people in Ireland - a focus on benzodiazepines
Murphy, K. D. (2014) · Arrow@dit (Dublin Institute of Technology)
Recent guidelines for evidence-based pharmacological treatment of social anxiety disorder
Baldwin, D. S. (2016) · European Psychiatry · doi:10.1016/j.eurpsy.2016.01.907
Self-citationAbhängigkeit von Hypnotika und Tranquilizern
Soyka, M. (2015) · DNP - Der Neurologe und Psychiater · doi:10.1007/s15202-015-0843-0
Liječenje benzodiazepinima i potencijalno ovisničko ponašanje
Kelek, M., Slijepčević, M. K., Puharić, Z., Kiralj, R., & Salaj, T. (2016) · Hrvatski časopis za javno zdravstvo
Management of panic disorder in primary care
Davies, S., Nash, J. R., & Nutt, D. (2017) · Prescriber · doi:10.1002/psb.1530
Self-citationThe Development of Therapeutic Drugs for Insomnia
何, 华. (2017) · Hans Journal of Medicinal Chemistry · doi:10.12677/hjmce.2017.51001
Managing benzodiazepine dependence
Cosh, A., & Carslaw, H. (2017) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738017715275
Metadata
- Authors
- Baldwin, D. S., Aitchison, K., Bateson, A., Curran, H. V., Davies, S., Leonard, B., Nutt, D. J., Stephens, D. N., & Wilson, S.
- Affiliations
- University of Southampton (GB)
- University of Alberta (CA)
- Ross University School of Medicine (BB)
- University College London (GB)
- Centre for Addiction and Mental Health (CA)
- Ollscoil na Gaillimhe – University of Galway (IE)
- Imperial College London (GB)
- University of Sussex (GB)
- Corresponding author
- Baldwin, David S
- ORCID
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2013-09-24
- Volume
- 27
- Issue
- 11
- Pages
- 967-971
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2116273170
- Cited by
- 249
- References
- 7
- Citations by year
- 2026: 17 · 2025: 19 · 2024: 14 · 2023: 21 · 2022: 21 · 2021: 22 · 2020: 23 · 2019: 21 · 2018: 21 · 2017: 19 · 2016: 19 · 2015: 16 · 2014: 15
- FWCI
- 22.52
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Research Bank (Australian Catholic University) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- benzodiazepines, anxiolytics, hypnotics, benzodiazepine dependence, long-term benzodiazepine use, benefits and risks, clinical guidelines, anxiety disorders, insomnia
- MeSH terms
- Benzodiazepines, Humans, Hypnotics and Sedatives, Practice Guidelines as Topic, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
